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background: Granulomatosis with polyangiitis (GPA) is a rare vasculitis that can involve cardiac structures.
case:  A 43 year old lady presented with progressive exertional dyspnoea and orthopnoea. She was receiving treatment with rituximab and 
corticosteroids for c-ANCA positive GPA. Physical signs included a Cushingoid appearance, extensive peripheral oedema and an elevated JVP.
methods: Echocardiography demonstrated good biventricular systolic function, a diastolic septal bounce, dilated atria, exaggerated respiratory 
variation of Doppler forward flows and a normal E’. CTPA revealed small pleural effusions but no evidence of pulmonary embolism, GPA-related lung 
disease or pericardial calcification. Cardiac MRI demonstrated pericardial thickening (7mm), and inspiratory septal flattening with no features of 
intrinsic myocardial disease, corroborating the working diagnosis of constrictive pericarditis. Cardiac catheterisation confirmed typical constrictive 
haemodynamics. Cyclophosphamide therapy was considered but pericardial biopsies displayed established fibrosis only, with no active inflammation.
results: Symptoms persisted despite diuretic therapy and the patient was referred for pericardial stripping.
conclusions: This case highlights the need to consider constrictive pericarditis as a potential cause of heart failure with a normal ejection fraction 
and the utility of multimodality investigation to secure the diagnosis and to guide treatment.
